Oct. 13, 2020 |
|
Feb. 05, 2021 |
|
jRCT2071200043 |
Phase 1 study of DS-3201b to evaluate the effect of food (low-fat meal) on the pharmacokinetics in healthy subjects |
|
Phase 1 study of DS-3201b to evaluate the effect of food (low-fat meal) on the pharmacokinetics in healthy subjects |
Nagao Kiminori |
||
DAIICHI SANKYO Co.,Ltd. |
||
1-2-58, Hiromachi, Shinagawa-ku, Tokyo |
||
+81-3-6225-1111 |
||
dsclinicaltrial@daiichisankyo.co.jp |
||
Contact for Clinical Trial Information |
||
DAIICHI SANKYO Co.,Ltd. |
||
1-2-58, Hiromachi, Shinagawa-ku, Tokyo |
||
+81-3-6225-1111 |
||
dsclinicaltrial@daiichisankyo.co.jp |
Complete |
Nov. 09, 2020 |
||
Oct. 31, 2020 | ||
28 | ||
Interventional |
||
randomized controlled trial |
||
open(masking not used) |
||
uncontrolled control |
||
crossover assignment |
||
other |
||
1. Gender:males or females |
||
1. Having a history of hypersensitivity to any drugs or substances, or being idiosyncratic (eg, having penicillin allergy) |
||
20age old over | ||
45age old under | ||
Both |
||
Healthy subjects |
||
Oral administration |
||
Pharmacokinetic parameters of plasma concentration of total DS-3201a: |
||
PK: |
DAIICHI SANKYO Co.,Ltd. |
Hakata Clinic Institutional Review Board | |
6-18, Tenyamachi, Hakata-ku, Fukuoka-shi, Fukuoka | |
+81-92-283-7701 |
|
Approval | |
No |
|
none |